Loading clinical trials...
Loading clinical trials...
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHRU Amiens
Amiens, France
Start Date
February 10, 2025
Primary Completion Date
November 1, 2026
Completion Date
May 1, 2027
Last Updated
January 16, 2026
30
ESTIMATED participants
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
NCT06647069
NCT07371468
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06333483